Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v6.2.4)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-9

Query Trace: Insulin Resistance and FAAH[orginal query]

Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture. PloS one 2015 10 (11): e0142728. Martins Cyro José de Moraes, Genelhu Virginia, Pimentel Marcia Mattos Gonçalves, Celoria Bruno Miguel Jorge, Mangia Rogerio Fabris, Aveta Teresa, Silvestri Cristoforo, Di Marzo Vincenzo, Francischetti Emilio Anton Similar articles in PubMed
Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients. Journal of endocrinological investigation 2013 Dec 36 (11): 965-9. de Luis D A, Izaola O, Aller R, de La Fuente B, Pacheco Similar articles in PubMed
385 C/A polymorphism of the fatty acid amide hydrolase gene is associated with metabolic syndrome in the Chinese Han population. Archives of medical science : AMS 2011 Jun 7 (3): 423-7. Zeng Jinyang, Li Jianrong, Huang Guolia Similar articles in PubMed
C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2. Diabetes research and clinical practice 2010 Apr 88 (1): 76-80. de Luis D A, Sagrado M Gonzalez, Aller R, Izaola O, Conde R, Romero Similar articles in PubMed
C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females. International journal of obesity (2005) 2010 Mar 34 (3): 511-5. de Luis D A, Gonzalez Sagrado M, Aller R, Izaola O, Conde R, Romero Similar articles in PubMed
Genetic variation in the FAAH gene and metabolic syndrome-related phenotypes. Obesity (Silver Spring, Md.) 2009 Nov 17 (11): 1979-80. Burgueño Adriana L, Sookoian Silvia, Gianotti Tomas F, Gemma Carolina, Pirola Carlos Similar articles in PubMed
The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2008 Dec 40 (12): 907-10. Papazoglou D, Panagopoulos I, Papanas N, Gioka T, Papadopoulos T, Papathanasiou P, Kaitozis O, Papatheodorou K, Maltezos Similar articles in PubMed
Relation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) with obesity and insulin resistance. Nutrición hospitalaria 0 25 (6): 993-8. de Luis D A, González Sagrado M, Aller R, Izaola O, Conde Similar articles in PubMed
Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance. Journal of diabetes and its complications 0 26 (4): 328-32. de Luis D A, Aller R, Izaola O, Conde R, Sagrado M Gonzalez, Primo D, Castro M Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Mar 16, 2019
Page last updated:Jun 03, 2020
Content source:

TOP